Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial
Kelley R. Branch, Jeffrey L. Probstfield, Jackie Bosch, Deepak L. Bhatt, Aldo P. Maggioni, Eva Muehlhofer, Álvaro Avezum, Petr Widimský, Stuart J. Connolly, Quilong Yi, Olga Shestakovska, Salim Yusuf, John W. Eikelboom
Topics & Concepts
MedicineRivaroxabanAspirinCompassCoronary artery diseasePeripheralInternal medicineCardiologyArterial diseaseClinical trialVascular diseaseWarfarinAtrial fibrillationGeographyCartographyAntiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease ManagementAtrial Fibrillation Management and Outcomes